I-Mab is a Maryland-based clinical-stage biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases... Read more
I-Mab is a Maryland-based clinical-stage biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases... Read more
News
IPO Rumors
Oct 16, 2025
Marketscreener
I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences
Leadership Change
Sep 12, 2025
GlobalNewswire
Wei Fu is now Executive Chairman at I-MAB
Conference Presentation
Aug 21, 2025
Benzinga
I-Mab to Participate in September Investor Conferences
Funding
Aug 02, 2025
PR Newswire
I-MAB received $30.9M in Post-IPO Equity Funding
Acquisition
Jul 17, 2025
GlobeNewswire
I-MAB acquired Bridge Health Biotech Co., Ltd. for undisclosed amount
I-MAB Competitors
1
2
3
4
5
6
7
8
9
10